DE69222151D1 - Therapeutische verwendung von pycnogenolen zur herstellung eines medikamentes mit antiinflammatorischer wirkung - Google Patents

Therapeutische verwendung von pycnogenolen zur herstellung eines medikamentes mit antiinflammatorischer wirkung

Info

Publication number
DE69222151D1
DE69222151D1 DE69222151T DE69222151T DE69222151D1 DE 69222151 D1 DE69222151 D1 DE 69222151D1 DE 69222151 T DE69222151 T DE 69222151T DE 69222151 T DE69222151 T DE 69222151T DE 69222151 D1 DE69222151 D1 DE 69222151D1
Authority
DE
Germany
Prior art keywords
therapeutic use
pycnogenols
medicine
producing
inflammatory effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69222151T
Other languages
English (en)
Other versions
DE69222151T2 (de
Inventor
Monique Tits
Luc Angenot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOLISOS LAB
Original Assignee
DOLISOS LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOLISOS LAB filed Critical DOLISOS LAB
Publication of DE69222151D1 publication Critical patent/DE69222151D1/de
Application granted granted Critical
Publication of DE69222151T2 publication Critical patent/DE69222151T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
DE69222151T 1991-02-15 1992-02-14 Therapeutische verwendung von pycnogenolen zur herstellung eines medikamentes mit antiinflammatorischer wirkung Expired - Fee Related DE69222151T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9101842A FR2672800B1 (fr) 1991-02-15 1991-02-15 Nouvelle utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire.
PCT/FR1992/000147 WO1992014457A1 (fr) 1991-02-15 1992-02-14 Utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire

Publications (2)

Publication Number Publication Date
DE69222151D1 true DE69222151D1 (de) 1997-10-16
DE69222151T2 DE69222151T2 (de) 1998-03-05

Family

ID=9409777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222151T Expired - Fee Related DE69222151T2 (de) 1991-02-15 1992-02-14 Therapeutische verwendung von pycnogenolen zur herstellung eines medikamentes mit antiinflammatorischer wirkung

Country Status (8)

Country Link
EP (1) EP0571520B1 (de)
AT (1) ATE157868T1 (de)
DE (1) DE69222151T2 (de)
DK (1) DK0571520T3 (de)
ES (1) ES2109347T3 (de)
FR (1) FR2672800B1 (de)
GR (1) GR3025410T3 (de)
WO (1) WO1992014457A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2699819B1 (fr) * 1992-12-28 1995-02-24 Dolisos Lab Utilisation de prodelphinidines pour l'obtention de médicaments destinés au traitement de l'arthrose.
DE19830650C1 (de) * 1998-07-09 1999-08-12 Lohmann Therapie Syst Lts Trockenkopierprozeß zur Herstellung flächiger, einzeldosierter Wirkstoffzubereitungen
KR100509119B1 (ko) * 1999-07-16 2005-08-18 주식회사 엘지생활건강 프로시아니딘 올리고머를 유효성분으로 하는 약제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
DE2740346A1 (de) * 1976-09-08 1978-03-09 Inverni Della Beffa Spa Arzneimittel und verfahren zu ihrer herstellung
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
FR2624737B1 (fr) * 1987-12-22 1991-04-05 Natura Medica Laboratoires Extrait de feuilles de cassis obtenu par extraction hydroalcoolique, procede de preparation d'un tel extrait; et composition therapeutique, notamment a activite antalgique et anti-inflammatoire comprenant un tel extrait

Also Published As

Publication number Publication date
DK0571520T3 (da) 1998-04-27
EP0571520B1 (de) 1997-09-10
GR3025410T3 (en) 1998-02-27
FR2672800A1 (fr) 1992-08-21
FR2672800B1 (fr) 1995-03-10
ATE157868T1 (de) 1997-09-15
WO1992014457A1 (fr) 1992-09-03
EP0571520A1 (de) 1993-12-01
ES2109347T3 (es) 1998-01-16
DE69222151T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
GEP20002210B (en) Acridine Derivatives
ATE133336T1 (de) Verwendung von rapamycin zur herstellung eines arzneimittels zur behandlung von augenentzündungen
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
RU92016313A (ru) Новые аналоги витамина d, способ их получения, промежуточное соединение, формкомпозиция и способ лечения
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
NO933200L (no) Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
ES8504737A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ATE135573T1 (de) Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DE69222151D1 (de) Therapeutische verwendung von pycnogenolen zur herstellung eines medikamentes mit antiinflammatorischer wirkung
ATE146185T1 (de) 11beta-substituierte 14,17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE3781879D1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FI870460A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
AU2670284A (en) 2-n-cycloalkylmethyl-3-oxo-5,6-diaryl-as-triazines
EP0241292A3 (de) Schmerzlindernde, in 4-Stellung substituierte Octahydrochinolizin-Verbindungen und Octahydrochinolizinium Zwischenprodukte
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee